Cleared Traditional

K142424 - DR300 HOLTER MONITOR

K142424 is an FDA 510(k) clearance for DR300 HOLTER MONITOR, manufactured by North East Monitoring, Inc.. The device is a Class 2 Cardiovascular device with product code MWJ cleared through the Traditional 510(k) pathway after a 88-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2014
Decision
88d
Days
Class 2
Risk

K142424 is an FDA 510(k) clearance for the DR300 HOLTER MONITOR. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by North East Monitoring, Inc. (Maynard, US). The FDA issued a Cleared decision on November 25, 2014 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all North East Monitoring, Inc. devices

FDA 510(k) Submission Details - K142424

510(k) Number K142424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2014
Decision Date November 25, 2014
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 125d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWJ Device Classification - Class 2, Special Controls

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 15
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K142424.
Eclipse PRO
K211651 · Spacelabs Healthcare, Ltd. · Nov 2021
Integrated CardioRespiratory System
K173156 · Sensydia, Inc. · Jun 2018
H3+ Holter Recorder
K152626 · Mortara Instrument, Inc. · Feb 2016
BTL-08 ECG RECORDER MODEL BTL-08 ECG LC PLUS, BTL-08 ECG LT PLUS
K100310 · BTL Industries, Inc. · Oct 2010
SEER LIGHT EXTEND COMPACT DIGITAL HOLTER SYSTEM
K050731 · Ge Medical Systems Information Technologies · May 2005
HOLTER RECORDER H3+
K043010 · Mortara Instrument, Inc. · Feb 2005